Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Boston, MA
NPI
1780602227
Since 2006
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Longwood Ave, Fegan 9
Boston, MA, 02115
Phone (617) 355-7970
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,958
60 services
Medicare patients, 2024
16
Average age 30
Drug cost, 2024
$490K
663 prescriptions
Company payments, 2025
$65.52
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Masanori Takeoka was code 99215 (office e&m - established), 20 times for 12 patients. In total Masanori Takeoka billed 60 services in 9 codes, and Medicare paid $3,958.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 20 | 12 | $122.76 | $2,455 |
By year: 2022 $3,049 for 43 services; 2023 $4,576 for 59 services; 2024 $3,958 for 60 services.
Medicare prescription drug claims, 2024
In 2024, the drug Masanori Takeoka prescribed most often to Medicare patients was Clobazam, with 83 prescriptions and refills. In total Masanori Takeoka wrote 663 Medicare prescriptions that cost $490K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobazam Generic | 83 | 89 | Under 11 | $7,546 |
| Divalproex Sodium Er Divalproex Sodium | 46 | 46 | Under 11 | $3,761 |
| Epidiolex Cannabidiol (Cbd) | 35 | 36 | Under 11 | $105K |
| Memantine Hcl Generic | 33 | 33 | Under 11 | $429 |
| Levetiracetam Er Levetiracetam | 32 | 42 | Under 11 | $9,933 |
| Topiramate Generic | 31 | 35 | Under 11 | $1,620 |
| Lamotrigine Generic | 29 | 45 | Under 11 | $385 |
| Lamictal Xr Lamotrigine | 25 | 25 | Under 11 | $59K |
| Gabapentin Generic | 24 | 24 | Under 11 | $928 |
| Oxtellar Xr Oxcarbazepine | 21 | 41 | Under 11 | $68K |
| Divalproex Sodium Generic | 20 | 20 | Under 11 | $3,496 |
| Lamotrigine Er Lamotrigine | 19 | 35 | Under 11 | $2,241 |
| Lacosamide Generic | 18 | 49 | Under 11 | $2,264 |
| Ethosuximide Generic | 18 | 23 | Under 11 | $1,805 |
| Briviact Brivaracetam | 17 | 37 | Under 11 | $38K |
Brand drugs: 164 claims; generic drugs: 484 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Masanori Takeoka $65.52 ($65.52 in general payments such as food, travel and fees) from 1 company. The largest payer was Jazz Pharmaceuticals Inc. with $65.52.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $65.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.